Dry Eye

• Remove contact lenses before using MIEBO™ and wait for at least 30 minutes before reinserting.
• It is important to use MIEBO™ exactly as prescribed.
• It is not known if MIEBO™ is safe and effective in children under the age of 18.
• The most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness). 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information for MIEBO™.

• XIIDRA® is contraindicated in patients with known hypersensitivity to lifitegrast or to any of the other ingredients.
• In clinical trials, the most common adverse reactions reported in 5-25% of patients were instillation site irritation, dysgeusia and reduced visual acuity. Other adverse reactions reported in 1% to 5% of the patients were blurred vision, conjunctival hyperemia, eye irritation, headache, increased lacrimation, eye discharge, eye discomfort, eye pruritus and sinusitis.
• To avoid the potential for eye injury or contamination of the solution, patients should not touch the tip of the single-use container to their eye or to any surface.
• Contact lenses should be removed prior to the administration of XIIDRA® and may be reinserted 15 minutes following administration.
• Safety and efficacy in pediatric patients below the age of 17 years have not been established.

Click here for full Prescribing Information for XIIDRA®.